Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Pharm Biol ; 54(7): 1263-71, 2016 Jul.
Article in English | MEDLINE | ID: mdl-26194070

ABSTRACT

CONTEXT: Obesity is the main risk factor for type 2 diabetes mellitus. Secondary metabolites with biological activities and pharmacological potential have been identified in species of the Baccharis genus that are specifically distributed in the Americas. OBJECTIVE: This study evaluated the effects of methanol extracts from Baccharis dracunculifolia DC. Asteraceae on metabolic parameters, satiety, and growth in monosodium glutamate (MSG) induced-obesity model rats. MATERIALS AND METHODS: MSG was administered to 32 newborn rats (4 mg/g of body weight) once daily for 5 consecutive days. Four experimental groups (control, control + extract, MSG, and MSG + extract) were treated for 30 consecutive days with 400 mg/kg of B. dracunculifolia extract by gavage. Biochemical parameters, antioxidant activity, total extract phenolic content (methanolic, ethanolic, and acetone extractions), and pancreatic islets were evaluated. RESULTS: High levels of phenolic compounds were identified in B. dracunculifolia extracts (methanol: 46.2 ± 0.4 mg GAE/L; acetate: 70.5 ± 0.5 mg GAE/L; and ethanol: 30.3 ± 0.21 mg GAE/L); high antioxidant activity was detected in B. dracunculifolia ethanol and methanol extracts. The concentration of serum insulin increased 30% in obese animals treated with extract solutions (1.4-2.0 µU/mL, p < 0.05). Insulin secretion in pancreatic islets was 8.3 mM glucose (58%, p < 0.05) and 16.7 mM (99.5%, p < 0.05) in rats in the MSG + extract and MSG groups, respectively. DISCUSSION AND CONCLUSION: Treatment with B. dracunculifolia extracts protected pancreatic islets and prevented the irreversible cellular damage observed in animals in obesity and diabetes models.


Subject(s)
Anti-Obesity Agents/pharmacology , Baccharis , Blood Glucose/drug effects , Hypoglycemic Agents/pharmacology , Insulin/metabolism , Islets of Langerhans/drug effects , Methanol/chemistry , Obesity/drug therapy , Plant Extracts/pharmacology , Sodium Glutamate , Solvents/chemistry , Animals , Animals, Newborn , Anti-Obesity Agents/isolation & purification , Antioxidants/isolation & purification , Antioxidants/pharmacology , Baccharis/chemistry , Blood Glucose/metabolism , Disease Models, Animal , Hypoglycemic Agents/isolation & purification , Insulin Resistance , Insulin Secretion , Islets of Langerhans/metabolism , Male , Obesity/chemically induced , Obesity/metabolism , Obesity/physiopathology , Phytotherapy , Plant Extracts/isolation & purification , Plants, Medicinal , Rats, Wistar , Time Factors
2.
Food Chem Toxicol ; 58: 324-31, 2013 Aug.
Article in English | MEDLINE | ID: mdl-23684757

ABSTRACT

Malva sylvestris has been used since ancient times for its emollient, laxative and anti-inflammatory properties, being extensively used as salads, soups and teas. The preset study evaluated the topical anti-inflammatory action of M. sylvestris hydroalcoholic extract (HE) and its compounds in mice ear inflammation caused by 12-O-tetradecanoylphorbol-acetate in mice. The LC-MS analysis of the HE confirmed the presence of scopoletin, quercetin and malvidin 3-glucoside compounds in the HE of M. sylvestris. Topical application of the HE reduced ear oedema, polymorphonuclear cells influx (myeloperoxydase activity and histological analysis) and interleukin-1ß levels in the tissue. The topical application of the compound present in the HE, malvidin 3-glucoside was also able to inhibit ear oedema and leukocytes migration. The other tested compounds, scopoletin, quercetin and malvidin 3,5-glucoside were able to prevent the formation of oedema and cell infiltration, but with less effectiveness when compared to HE and malvidin 3-glucoside. Therefore, these results consistently support the notion that M. sylvestris leaves possesses topical anti-inflammatory activity, the compound malvidin 3-glucoside seems to be major responsible for this effect, with the participation of other anti-inflammatory compounds in the extract. Thus, as recommended by population, M. sylvestris can be used as a future treatment to skin disorders.


Subject(s)
Anti-Inflammatory Agents/pharmacology , Malva/chemistry , Plants, Medicinal , Animals , Anti-Inflammatory Agents/chemistry , Chromatography, Liquid , Female , Interleukin-1beta/metabolism , Mice , Peroxidase/metabolism , Spectrometry, Mass, Electrospray Ionization
3.
J Oral Sci ; 52(1): 23-32, 2010 Mar.
Article in English | MEDLINE | ID: mdl-20339229

ABSTRACT

This study was done to assess the influence of the topical application of two different desensitizing agents on dentin permeability and dentinal tubule occlusion. Twenty-one rats provided 84 teeth: 36 for the in vitro and 48 for the in vivo investigation. The following agents were tested: Group 1, 2% potassium nitrate plus 2% sodium fluoride gel; Group 2, 5% sodium fluoride varnish; Group 3, 3% hydroxyethylcellulose gel (control). Cervical cavities were prepared and EDTA was applied to expose the dentinal tubules. After each treatment, Evans blue dye was applied to the teeth. Dentin permeability, scanning electron microscope (SEM) sections, and energy dispersive X-ray (EDX) were analyzed. One-way ANOVA was used to compare the data. There were significant differences (P < 0.05) among groups for dentin permeability, number of tubules/mm(2), tubule area and tubular diameter. Groups 1 and 2 (both in vitro and in vivo) showed open and partially occluded tubules. Group 3 had the most open tubules. EDX revealed similar composition for both experimental conditions. Within the limits of the study, 2% nitrate potassium plus 2% sodium fluoride gel and 5% fluoride varnish decreased the dentin permeability, resulting in partial tubular occlusion.


Subject(s)
Dentin Desensitizing Agents/pharmacology , Dentin Permeability/drug effects , Nitrates/pharmacology , Potassium Compounds/pharmacology , Sodium Fluoride/pharmacology , Animals , Dentin/drug effects , Dentin/ultrastructure , Drug Combinations , Fluorides, Topical , Male , Microscopy, Electron, Scanning , Random Allocation , Rats , Rats, Wistar , Reproducibility of Results , Spectrometry, X-Ray Emission
4.
Community Dent Oral Epidemiol ; 37(5): 463-7, 2009 Oct.
Article in English | MEDLINE | ID: mdl-19681983

ABSTRACT

OBJECTIVE: To evaluate the mechanical and chemical control of dental biofilm in patients with Down syndrome, using different experimental dentifrices. MATERIAL AND METHODS: Forty institutionalized children between ages 7 and 13 years in the mixed dentition phase participated in this study. An experimental cross-over, blind clinical trial was used, having the following protocols: fluoridated dentifrice (protocol G1); fluoridated dentifrice + chlorhexidine (protocol G2); fluoridated dentifrice + chlorhexidine + plaque-disclosing agent (protocol G3); and fluoridated dentifrice + plaque-disclosing agent (protocol G4). Each experimental stage lasted 10 days with a 15-day washout. The evaluated parameters were Plaque Index and gingival bleeding. RESULTS: The initial clinical conditions between each stage were similar. Statistical differences were observed (P < 0.001) for the clinical conditions evaluated before and after the treatments. The dentifrices containing plaque-disclosing agent, irrespective of their association with chlorhexidine, produced a greater reduction in the final plaque index. As for gingival bleeding, the dentifrice containing erythrosine and the one containing chlorhexidine produced similar results. The dentifrice containing an association of chlorhexidine and erythrosine gave the best results. CONCLUSION: With the methodology employed, it was possible to conclude that the combination of drugs (chlorhexidine, fluorine and erythrosine) within one dentifrice can be useful in controlling dental biofilm and in the reduction of gingival bleeding.


Subject(s)
Dental Care for Disabled/methods , Dental Plaque/prevention & control , Down Syndrome/complications , Adolescent , Biofilms , Cariostatic Agents/therapeutic use , Child , Chlorhexidine/therapeutic use , Cross-Over Studies , Dentifrices/therapeutic use , Double-Blind Method , Female , Fluorides/therapeutic use , Humans , Male , Mouthwashes/therapeutic use , Periodontal Index
SELECTION OF CITATIONS
SEARCH DETAIL
...